Compare CNMD & NBXG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | CNMD | NBXG |
|---|---|---|
| Founded | 1970 | 2021 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Electromedical & Electrotherapeutic Apparatus | Trusts Except Educational Religious and Charitable |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.4B | 1.1B |
| IPO Year | 1987 | N/A |
| Metric | CNMD | NBXG |
|---|---|---|
| Price | $39.26 | $14.15 |
| Analyst Decision | Hold | |
| Analyst Count | 6 | 0 |
| Target Price | ★ $53.67 | N/A |
| AVG Volume (30 Days) | ★ 613.8K | 243.7K |
| Earning Date | 11-05-2025 | 01-01-0001 |
| Dividend Yield | 1.96% | ★ 10.25% |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 2.05 | N/A |
| Revenue | ★ $1,347,470,000.00 | N/A |
| Revenue This Year | $6.81 | N/A |
| Revenue Next Year | $5.23 | N/A |
| P/E Ratio | $19.92 | ★ N/A |
| Revenue Growth | ★ 4.61 | N/A |
| 52 Week Low | $38.32 | $9.31 |
| 52 Week High | $74.75 | $12.23 |
| Indicator | CNMD | NBXG |
|---|---|---|
| Relative Strength Index (RSI) | 37.57 | 37.27 |
| Support Level | $38.32 | $14.67 |
| Resistance Level | $41.16 | $14.69 |
| Average True Range (ATR) | 1.67 | 0.22 |
| MACD | -0.16 | -0.04 |
| Stochastic Oscillator | 16.25 | 8.57 |
Conmed Corp is a Utica, New York-based medical equipment company that focuses on sports medicine procedures and general surgeries. The Company's products are used by surgeons and other healthcare professionals in a variety of specialties including orthopedics, general surgery, gynecology, thoracic surgery and gastroenterology. Geographically operates in USA, Europe, Middle East & Africa, Asia Pacific and North America. Majority is revenue is from USA.
Neuberger Berman Next Generation Connectivity Fund Inc. is a non-diversified, closed-end management investment company. The fund's investment objectives are to provide capital appreciation and income. Under normal market conditions, the Fund will invest at least 80% of its total assets in equity securities issued by U.S. and non-U.S. companies, in any market capitalization range, that is relevant to the theme of investing in "NextGen Companies".